Skip to main content
. 2021 May 4;100(7):1837–1847. doi: 10.1007/s00277-021-04521-z

Fig. 3.

Fig. 3

Subgroup analyses. Impact of ATG dose on (a) OS, (b) GRFS, (c) grade III–IV aGVHD, and (d) moderate/severe cGVHD according to baseline patients’ characteristics